The Latest

Study Finds Over 90% of all Generic Drugs Dependent on Imports

Other countries have made investments in API facilities; the U.S. is falling further behind.

FDA’s Latest Eye Drop Recalls Are All Made Overseas

The FDA recalled 28 different eye drop products sold over-the-counter in retail pharmacies like CVS and Target.

Indian Generic Drug Exporters Have A Month Full Of Recalls

This summer ended with one recall after the next for Indian pharmaceutical companies that export generic drugs to the United States.

Glass in Vial Forces Indian Multinational Drug Company Aurobindo to Recall Products In U.S.

Aurobindo recalled 1,626 vials of Triamcinolone Acetonide Injectable Suspension, an important generic corticosteroid treatment.

FDA Says U.S. Approved India Psychotropic Drug Maker Has Dirty Lab

The FDA is returning to a normal overseas inspection workload. What they are finding is not pretty.

FDA Again Allows Unapproved Chinese Chemotherapy Drugs into the U.S.

The FDA approved Qilu Pharmaceuticals from Shandong, China, to sell the generic oncology drug cisplatin along with carboplatin.

Generic Drugs Maker Intas Pharmaceuticals Keeps Failing Inspections

Intas received 16 “observations” on their Form 483 inspection report.

At India Drug Maker Aurobindo Lab, FDA Finds “Deficient” Manufacturing Equipment

America’s drug supply is increasingly reliant on companies who continually get failing grades from the Food & Drug Administration.